187 Real-world treatment patterns and clinical predictors of overall survival among anti-PD-1 exposed advanced melanoma patients with documented evidence of disease progression

• Xiaoyun Li,
• Xinyue Liu,
• Cathy Anne Pinto,
• Emilie Scherrer,
• Mizuho Kalabis

Affiliations

Xiaoyun Li

1 Department of Anesthesiology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

Xinyue Liu

Merck and Co., Inc, Rahway, NJ, USA

Cathy Anne Pinto

Merck and Co., Inc, Rahway, NJ, USA

Emilie Scherrer

Merck and Co., Inc, Rahway, NJ, USA

Mizuho Kalabis

Merck and Co., Inc, Rahway, NJ, USA